Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04897334 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
A NA study of Cognitive Impairment and Ischemic Stroke, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT04897334: Recruiting NA study of Cognitive Impairment and Ischemic Stroke, sponsored by University of Pennsylvania.
NCT04897334 is a NA study of Cognitive Impairment and Ischemic Stroke that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 70 participants, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04897334, a NA study of Cognitive Impairment and Ischemic Stroke, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a non-invasive brain stimulation technique, transcranial direct current stimulation (tDCS), combined with traditional cognitive therapy will improve cognitive function in patients with subacute stroke.
Primary Outcome
This psychometric test covers multiple domains of cognition, comes in multiple versions to avoid practice effect, is validated in the brain injury population and can be administered in 20-30 minutes. Possible scores on the RBANS range from 40 to 160 where a higher score indicates a better outcome.
Conditions Studied
Interventions
- DEVICE sham tDCS
- DEVICE tDCS
- BEHAVIORAL Cognitive Therapy
Study Locations (1)
Pennsylvania
- Penn Medicine Rehabilitation - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2021-09-21 |
| Est. Completion | 2028-01 |
| Phase | NA |
What NCT04897334 shows while recruiting
NCT04897334 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 665-participant average among 105 other Cognitive Impairment trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Cognitive Impairment appearing as the primary indexed condition, and to 3 interventions - of which sham tDCS is the first listed.
NCT04897334 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04897334 about?
NCT04897334 is a clinical study titled "Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke". The purpose of this study is to determine whether a non-invasive brain stimulation technique, transcranial direct current stimulation (tDCS), combined with traditional cognitive therapy will improve cognitive function in patients with subacute stroke.
What is the current status of trial NCT04897334?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2021-09-21. Estimated completion is 2028-01.
What conditions does trial NCT04897334 study?
This clinical trial studies the following conditions: Cognitive Impairment, Ischemic Stroke.
What interventions are being tested in trial NCT04897334?
The interventions under investigation include: sham tDCS (DEVICE), tDCS (DEVICE), Cognitive Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04897334?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04897334 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04897334's enrollment target sits among peer trials
70 61st of 105 higher than 45 of 105 other Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
-
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistical Pilot Study
RECRUITING · NA
-
Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
-
Train Your Brain SC: Exercise for People With Mild-moderate Cognitive Impairments
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI